Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Morphine extended release - AbbVie

Drug Profile

Morphine extended release - AbbVie

Alternative Names: KADIAN; KAPANOL

Latest Information Update: 28 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Faulding Laboratories
  • Developer Alpharma; Faulding Laboratories
  • Class Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Dyspnoea; Pain
  • Registered Opioid-related disorders

Most Recent Events

  • 03 Jun 2024 Swissmedic, the national authorisation and supervisory authority for drugs and medical products approves morphine sulfate pentahydrate 10 mg and 200 mg capsule for Opioid-related disorders in Opioid-related disorders
  • 27 Jan 2022 Mayne Pharma International terminates a phase-III pRESTO trial as study was unable to proceed per protocol due to COVID-19 precautions, in Opioid-related disorders in Canada (PO) (NCT03948464)
  • 08 May 2020 Allergan has been acquired and merged into AbbVie

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top